Post by Ibrahim Kamara

McDermott Will & Schulte represented Ren Life Sciences on its investment in AMW GmbH, a company specialising in the development and commercialisation of long acting formulations of sterile injectable drugs. Growth in the number of complex large molecule medicines which require parenteral administration is driving demand for technology which can extend the therapeutic window. In turn, this improves patient access, comfort and adherence. Ren Life Sciences and Juno Capital Partners invested alongside existing shareholders SHS Capital and AMW Evolution. Congratulations to our client and McDermott’s cross-border deal team which was led by private equity partner Fatema Orjela and included Zoe Woodhouse, Raees Khan, Sofia Vargas Velasco, Alex Jupp, Raminta Dereskeviciute, Johannes Eckhardt, Dr. Carsten Böhm, Sebastian Bonk, Philipp Grenzebach, Manuel Weiss, Carlota Huth, Julia Külzer, Dustin Schwerdtfeger, Florian Schiefer, Dr. Laura A. Stammwitz, Jana Grieb, Dr. Boris Uphoff, Steffen Woitz, Dr. Maximilian Clostermeyer, Christian Rolf, Claus Faerber, Matthias M. Bosbach, Carolin Schumacher, Carina Schützeberg, Paulina Simons, Athanasia Eleftheriadou and Dr. Thomas Hintzen. https://lnkd.in/eYXyhyfM #privateequity #lifesciences #manufacturing #mcdermott